Atrial fibrillation (main): Difference between revisions

Line 43: Line 43:
#Digoxin level (if appropriate)
#Digoxin level (if appropriate)
#Chem-10
#Chem-10
#TSH
#TSH & free T4 (AF increased in subclinical hyperthyrodism)
 
Special cases:
*Eval for ACS/MI
**In pt with ECG changes, hypotension, angina
***AF is rarely only manifestation of ACS, although RVR and hypotension can provoke demand ischemia


==Treatment==
==Treatment==

Revision as of 03:54, 24 October 2013

Background

Atrial fibrillation (AF) categories:

  • First detected episode
  • Recurrent (after 2 or more episodes)
  • Paroxysmal (if recurrent AF terminates spontaneously)
  • Persistent (if sustained beyond 7 days)

Causes:

  • Cardiac (atrial enlargement)
    • Hypertension
    • Ischemic heart disease
    • Rheumatic heart disease
  • Noncardiac (increased automaticity)
    • Thyrotoxicosis
    • Chronic lung disease
    • Pericarditis
    • Ethanol ("holiday heart")
    • PE
    • Drugs (cocaine, TCA)

Clinical Features

  1. Asymptomatic - 44%
  2. Palpitations - 32%
  3. Dyspnea - 10%
  4. Stroke - 2%
  5. Also can present with decompensated heart failure, acute pulmonary edema

Diagnosis

  • 3 patterns on ECG:
  1. Typical
    1. Irregularly, irregular R waves
    2. QRS rate 140-160/min
  2. Large fibrillatory waves
    1. May look like flutter waves
      1. Unlike a-flutter, the fibrillatory waves are irregular
  3. Slow, regular A-fib
    1. Due to complete AV block with escape rhythm
  • Ischemic changes?
  • Rate > 250? (think preexcitation)

Work-Up

  1. ECG
  2. Digoxin level (if appropriate)
  3. Chem-10
  4. TSH & free T4 (AF increased in subclinical hyperthyrodism)

Special cases:

  • Eval for ACS/MI
    • In pt with ECG changes, hypotension, angina
      • AF is rarely only manifestation of ACS, although RVR and hypotension can provoke demand ischemia

Treatment

  • Rate control
  • Anti-thrombotic therapy
    • Chronic and paroxysmal a fib are associated with thrombus formation

CHADS2 Score

  1. CHF (1pt)
  2. HTN (1pt)
  3. Age>75 (1pt)
  4. DM (1pt)
  5. Stroke/TIA (2pts)
  • Score 0: consider no treatment or ASA
  • Score 1: consider warfarin or ASA
  • Score 2-6: consider warfarin (INR goal = 2-3)
  • All patients with valvular disease should be on anticoagulation

Disposition

  • Consider discharge for paroxysmal A-fib successfully treated if none of the following:
    • Hemodynamic instability
    • Myocardial ischemia
    • CHF exacerbation
    • Symptomatic recurrence in the ED

Complications

  1. Hemodynamic compromise
    1. A-fib lowers CO by 20-30%
    2. Impaired coronary blood flow
  2. Arrhythmogenesis
  3. Arterial thromboembolism

See Also

Source

  • UpToDate
  • Annals of EM; Jan 2011. 57(1)